Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Survival of Peripheral T-Cell Lymphomas (PTCLs) Patients Following Relapse: Spectrum of Disease and Rare Long-Term Survivors

Vivien Mak, MBBS FHKAM, Joseph M. Connors, MD, Richard Klasa, MD, Laurie H. Sehn, MD, MPH, Diego Villa, MD, MPH, Tamara Shenkier, MD, Mukesh Chhanabhai, MD, Randy D. Gascoyne, MD, Kerry J. Savage, MD MSc

Blood (2011) 118 (21): 96.

https://doi.org/10.1182/blood.V118.21.96.96

Published: 2011

Journal Articles

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

Blood (2011) 117 (26): 7070–7078.

https://doi.org/10.1182/blood-2011-04-345256

Published: 2011

Includes: Supplemental data

Journal Articles

The Prognosis of Limited Stage Peripheral T-Cell Lymphoma (PTCL): A Population-Based Analysis and Comparison to Diffuse Large B-Cell Lymphoma (DLBCL)

Kerry Joanne Savage, MD, MSc, Hilary M O'Leary, MBBChBAO, MRCPI, MRCPath, Joseph M Connors, MD, Mukesh Chhanabhai, MD, Belinda Campbell, MD, Laurie H Sehn, MD, MPH, Randy D. Gascoyne, MD, R. Gregory Bociek, MD, James O. Armitage, MD, Dennis D. Weisenburger, MD, Julie M. Vose, Martin Bast, BS, Philip Bierman, MD

Blood (2010) 116 (21): 4129.

https://doi.org/10.1182/blood.V116.21.4129.4129

Published: 2010

Journal Articles

The International Prognostic Factor Project Score (IPS) in Advanced Stage Hodgkin Lymphoma Has Limited Utility in Patients Treated in the Modern Era.

Moccia A. Moccia, Jane Donaldson, Mukesh Chhanabhai, Paul Hoskins, Richard Klasa, Kerry J. Savage, Tamara Shenkier, Brian Skinnider, Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn

Blood (2009) 114 (22): 1554.

https://doi.org/10.1182/blood.V114.22.1554.1554

Published: 2009

Journal Articles

Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival

Nathalie A. Johnson, Merrill Boyle, Ali Bashashati, Stephen Leach, Angela Brooks-Wilson, Laurie H. Sehn, Mukesh Chhanabhai, Ryan R. Brinkman, Joseph M. Connors, Andrew P. Weng, Randy D. Gascoyne

Blood (2009) 113 (16): 3773–3780.

https://doi.org/10.1182/blood-2008-09-177469

Published: 2009

Includes: Supplemental data

Journal Articles

ALK − anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

Kerry J. Savage, Nancy Lee Harris, Julie M. Vose, Fred Ullrich, Elaine S. Jaffe, Joseph M. Connors, Lisa Rimsza, Stefano A. Pileri, Mukesh Chhanabhai, Randy D. Gascoyne, James O. Armitage, Dennis D. Weisenburger

Blood (2008) 111 (12): 5496–5504.

https://doi.org/10.1182/blood-2008-01-134270

Published: 2008

Includes: Supplemental data

Journal Articles

Both Discordant and Concordant Bone Marrow (BM) Involvement Predict for a Poorer Outcome Independent of the IPI in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP.

Laurie H. Sehn, MD, MPH, Mukesh Chhanabhai, MD, Suman Singh, Wayne Saville, MD, Dan Matso, PhD, John J. Spinelli, PhD, Joseph M. Connors, MD, Randy D. Gascoyne, MD

Blood (2007) 110 (11): 1559.

https://doi.org/10.1182/blood.V110.11.1559.1559

Published: 2007

Journal Articles

Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP-R Can Be Predicted by Stage and Serum Lactate Dehydrogenase (LDH) Level.

Laurie H. Sehn, MD, MPH, Mukesh Chhanabhai, MD, Karamjit Gill, MD, Paul Hoskins, MD, Richard Klasa, MD, Kerry J. Savage, MD, Tamara Shenkier, MD, Judy Sutherland, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD

Blood (2006) 108 (11): 2739.

https://doi.org/10.1182/blood.V108.11.2739.2739

Published: 2006

Journal Articles

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Laurie H. Sehn, Brian Berry, Mukesh Chhanabhai, Catherine Fitzgerald, Karamjit Gill, Paul Hoskins, Richard Klasa, Kerry J. Savage, Tamara Shenkier, Judy Sutherland, Randy D. Gascoyne, Joseph M. Connors

Blood (2006) 109 (5): 1857–1861.

https://doi.org/10.1182/blood-2006-08-038257

Published: 2006

Journal Articles

Bone Marow (BM) Involvement in Diffuse Large B Cell Lymphoma (DLBCL): Clinical Impact of Discordant Disease.

Mukesh Chhanabhai, FRCPC, Joseph Connors, MD, Wayne Seville, MD, Dan Matso, PhD, Randy Gascoyne, MD

Blood (2006) 108 (11): 2031.

https://doi.org/10.1182/blood.V108.11.2031.2031

Published: 2006

Journal Articles

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

Jane N. Winter, Edie A. Weller, Sandra J. Horning, Maryla Krajewska, Daina Variakojis, Thomas M. Habermann, Richard I. Fisher, Paul J. Kurtin, William R. Macon, Mukesh Chhanabhai, Raymond E. Felgar, Eric D. Hsi, L. Jeffrey Medeiros, James K. Weick, John C. Reed, Randy D. Gascoyne

Blood (2006) 107 (11): 4207–4213.

https://doi.org/10.1182/blood-2005-10-4222

Published: 2006

Journal Articles

Evaluation of a New Prognostic Index for Peripheral T-Cell Lymphoma, Unspecified (PTCL-US).

Heather L. McArthur, MD, Mukesh Chhanabhai, MD, Gascoyne D. Randy, MD, Connors M. Joseph, MD, Savage J. Kerry, MD

Blood (2005) 106 (11): 2812.

https://doi.org/10.1182/blood.V106.11.2812.2812

Published: 2005

Journal Articles

Survival of Limited Stage Peripheral T-Cell Lymphoma Is Similar To Diffuse Large B-Cell Lymphoma.

Kerry J. Savage, MD, Mukesh Chhanabhai, MD, Nicholas Voss, MD, Shenkier Tamara, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD

Blood (2005) 106 (11): 2817.

https://doi.org/10.1182/blood.V106.11.2817.2817

Published: 2005

Journal Articles

Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP).

Laurie H. Sehn, MD, MPH, Mukesh Chhanabhai, MD, Catherine Fitzgerald, MD, Karamjit Gill, MD, Paul Hoskins, MD, Richard Klasa, MD, Kerry Savage, MD, Tamara Shenkier, MD, Judy Sutherland, MD, Kenneth Wilson, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD

Blood (2005) 106 (11): 492.

https://doi.org/10.1182/blood.V106.11.492.492

Published: 2005

Journal Articles

Transformed Lymphoma: Incidence and Long-Term Outcome.

Abdulwahab J. Al-Tourah, MB, BCh, FRCPC, Mukesh Chhanabhai, MD, FRCPC, Paul J. Hoskins, MD, FRCPC, Richard J. Klasa, MD, FRCPC, Kerry J. Savage, MD, FRCPC, Laruie H. Sehn, MD, FRCPC, Tamara N. Shenkier, MD, FRCPC, Randy D. Gascoyne, MD, FRCPC, Joseph M. Connors, MD, FRCPC

Blood (2004) 104 (11): 3253.

https://doi.org/10.1182/blood.V104.11.3253.3253

Published: 2004

Journal Articles

Prognostic Significance of Anaplastic Lymphoma Kinase (ALK) Protein Expression in Adults With Anaplastic Large Cell Lymphoma

Randy D. Gascoyne, Patricia Aoun, Daniel Wu, Mukesh Chhanabhai, Brian F. Skinnider, Timothy C. Greiner, Stephan W. Morris, Joseph M. Connors, Julie M. Vose, David S. Viswanatha, Andrew Coldman, Dennis D. Weisenburger

Blood (1999) 93 (11): 3913–3921.

https://doi.org/10.1182/blood.V93.11.3913

Published: 1999

Journal Articles

Immunohistochemical Analysis of Interleukin-1β–Converting Enzyme/Ced-3 Family Protease, CPP32/Yama/Caspase-3, in Hodgkin's Disease

Mukesh Chhanabhai, Stanislaw Krajewski, Maryla Krajewska, Hong-Gang Wang, John C. Reed, Randy D. Gascoyne

Blood (1997) 90 (6): 2451–2455.

https://doi.org/10.1182/blood.V90.6.2451

Published: 1997

Journal Articles

Immunolocalization of the ICE/Ced-3–Family Protease, CPP32 (Caspase-3), in Non-Hodgkin's Lymphomas, Chronic Lymphocytic Leukemias, and Reactive Lymph Nodes

Stanislaw Krajewski, Randy D. Gascoyne, Juan M. Zapata, Maryla Krajewska, Shinichi Kitada, Mukesh Chhanabhai, Douglas Horsman, Ken Berean, Lawrence D. Piro, Isabelle Fugier-Vivier, Yong-Jun Liu, Hong-Gang Wang, John C. Reed

Blood (1997) 89 (10): 3817–3825.

https://doi.org/10.1182/blood.V89.10.3817

Published: 1997

NARROW

Survival of Peripheral T-Cell Lymphomas (PTCLs) Patients Following Relapse: Spectrum of Disease and Rare Long-Term Survivors

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

The Prognosis of Limited Stage Peripheral T-Cell Lymphoma (PTCL): A Population-Based Analysis and Comparison to Diffuse Large B-Cell Lymphoma (DLBCL)

The International Prognostic Factor Project Score (IPS) in Advanced Stage Hodgkin Lymphoma Has Limited Utility in Patients Treated in the Modern Era.

Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival

ALK − anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

Both Discordant and Concordant Bone Marrow (BM) Involvement Predict for a Poorer Outcome Independent of the IPI in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP.

Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP-R Can Be Predicted by Stage and Serum Lactate Dehydrogenase (LDH) Level.

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Bone Marow (BM) Involvement in Diffuse Large B Cell Lymphoma (DLBCL): Clinical Impact of Discordant Disease.

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

Evaluation of a New Prognostic Index for Peripheral T-Cell Lymphoma, Unspecified (PTCL-US).

Survival of Limited Stage Peripheral T-Cell Lymphoma Is Similar To Diffuse Large B-Cell Lymphoma.

Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP).

Transformed Lymphoma: Incidence and Long-Term Outcome.

Prognostic Significance of Anaplastic Lymphoma Kinase (ALK) Protein Expression in Adults With Anaplastic Large Cell Lymphoma

Immunohistochemical Analysis of Interleukin-1β–Converting Enzyme/Ced-3 Family Protease, CPP32/Yama/Caspase-3, in Hodgkin's Disease

Immunolocalization of the ICE/Ced-3–Family Protease, CPP32 (Caspase-3), in Non-Hodgkin's Lymphomas, Chronic Lymphocytic Leukemias, and Reactive Lymph Nodes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only